Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Pharmacology & Therapeutics|August 31, 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disordersSimone B Sartori, Nicolas Singewald
Future Neurology|September 9, 2011
The clinical implications of mouse models of enhanced anxietySimone B Sartori, Rainer Landgraf, Nicolas Singewald
Current Pharmaceutical Design|May 16, 2009
Tachykinin receptors as therapeutic targets in stress-related disordersKarl Ebner, Simone B Sartori, Nicolas Singewald
Neuropharmacology|January 9, 2023
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorderNicolas Singewald, Simone B Sartori, Andreas Reif, et al.
Behavioural Brain Research|May 22, 2016
Dysregulation of select ATP-dependent chromatin remodeling factors in high trait anxietyAlexandra Wille, Thomas Amort, Nicolas Singewald, et al.
Pediatrics|November 14, 2007
Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain developmentNigel Whittle, Simone B Sartori, Mara Dierssen, et al.
Neuropharmacology|November 30, 2004
Magnesium-deficient diet alters depression- and anxiety-related behavior in mice--influence of desipramine and Hypericum perforatum extractNicolas Singewald, Catrin Sinner, Alfred Hetzenauer, et al.
Plos One|March 10, 2011
Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventionsSimone B Sartori, Markus Hauschild, Mirjam Bunck, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 18, 2013
Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behaviorClaudia Schmuckermair, Stefano Gaburro, Anupam Sah, et al.
Pageof 4